HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS

HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS was reported 17 times

HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRAZIQUANTEL 1 0.0033
1 PSYLLIUM HUSK 1 0.0007
2 DIMENHYDRINATE 5 0.0005
3 HUMAN IMMUNOGLOBULIN G 5 0.0002
4 INSULIN DEGLUDEC 5 0.0002
5 CANDESARTAN CILEXETIL 5 0.0002
6 TRAMADOL HYDROCHLORIDE 5 0.0001
7 TRETINOIN 1 0.0001
8 DEXLANSOPRAZOLE 5 0.0001
9 EZETIMIBE 5 0.0001
10 LAPATINIB 1 0.0001
11 SORAFENIB 1 0.0000
12 ATENOLOL 5 0.0000
13 FLUDARABINE PHOSPHATE 1 0.0000
14 ADALIMUMAB-FKJP 1 0.0000
15 ADALIMUMAB-AATY 1 0.0000
16 ADALIMUMAB-ADAZ 1 0.0000
17 METFORMIN ER 500 MG 5 0.0000
18 CARBAMAZEPINE 1 0.0000
19 PROPRANOLOL HYDROCHLORIDE 1 0.0000
20 RUXOLITINIB 1 0.0000
21 RISPERIDONE 1 0.0000
22 INSULIN LISPRO 1 0.0000
23 SPIRONOLACTONE 1 0.0000
24 ALLOPURINOL 1 0.0000
25 LANSOPRAZOLE 1 0.0000
26 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
27 CYCLOPHOSPHAMIDE 1 0.0000
28 RITUXIMAB 1 0.0000
29 INSULIN GLARGINE 1 0.0000
30 FUROSEMIDE 1 0.0000
31 LENALIDOMIDE 1 0.0000
32 DUPILUMAB 1 0.0000
33 ADALIMUMAB 1 0.0000